Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Cash Flows From Operating Activities:    
Net loss $ (15,380) $ (13,421)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 340 2,074
Common stock issued to vendor 0 26
Subsidiary stock issues to vendor 72 36
Warrant issued to vendor 0 9
Change in fair value of warrant liabilities 0 (4,083)
Depreciation 240 272
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (788) 234
Right of use asset 118 0
Accounts payable 1,282 (987)
Accrued expenses 857 (607)
Accrued employee benefits (397) (742)
Lease liability (217) 0
Deferred rent 0 (90)
Net Cash Used In Operating Activities (13,873) (17,279)
Cash Flows From Investing Activities:    
Purchases of property and equipment 0 (7)
Net Cash Used In Investing Activities 0 (7)
Cash Flows From Financing Activities:    
Proceeds from Units offering, net of issuance cost 0 16,916
Proceeds from "at the market" stock issuance 0 12,172
Net Cash Provided By Financing Activities 0 29,088
Net increase (decrease) increase in cash (13,873) 11,802
Cash and cash equivalents at beginning of year 28,918 17,116
Cash and cash equivalents at end of year 15,045 28,918
NONCASH FINANCING ACTIVITIES:    
Conversion of Series B Preferred Stock 999 4,042
Right of use asset from operating lease 537 0
In-kind dividends in preferred stock 248 243
Series B Preferred Stock [Member]    
NONCASH FINANCING ACTIVITIES:    
Deemed dividends for accretion $ 525 $ 11,681